Serial #76181344
DEAD

Serial Number

76181344

Owner

TRISTEM TRADING (CYPRUS) LIMITED

Attorney

Thomas J. Kowalski

Filing Date

Dec 15, 2000

Add to watchlist:

No watchlists yet
View on USPTO

Serial #76181344 Trademark

Serial Number: 76181344 • Registration: 2965443

Serial #76181344 is a trademark filed by TRISTEM TRADING (CYPRUS) LIMITED on December 15, 2000. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

TRISTEM TRADING (CYPRUS) LIMITED (3 trademarks)

c/o ANTIS TRIANTAFYLLIDES & SONS LLC
NICOSIA 1065 , CY

Entity Type: 03

Ghazi Dhoot (3 trademarks)

11 St. John's Park
London NW8 6QP , GB

Entity Type: 03

Trademark Details

Filing Date

December 15, 2000

Registration Date

July 12, 2005

Published for Opposition

April 19, 2005

Cancellation Date

February 19, 2016

Goods & Services

Laboratory apparatus for use in the production, modification and preparation and transdifferentiation of stem cells, differentiated cells and cell populations; laboratory apparatus, for use in measuring the growth of stem cells, checking the health of stem cells, analyzing and recording the differentiation process during the production of modified cells and cell populations, forming specialized stem cells from mature cells via retrodifferentiation, and use in measuring the growth of stem cells, checking the health of stem cells, analyzing and recording of prepared stem cells, differentiated cells and cell populations; computer software cartridges for controlling laboratory apparatus for production of cells and cell tissue for treating disorders and diseases in humans and animals, all the aforesaid goods for use on or in relating to human and animal cells

A HOUSE MARK FOR A FULL LINE OF PHARMACEUTICAL PREPARATIONS CONSISTING OF STEM CELLS AND DIFFERENTIATED STEM CELLS FOR THE PREVENTION AND TREATMENT OF DISEASES AND CONDITIONS IN HUMAN AND ANIMALS; BIOLOGICAL PREPARATIONS FOR USE IN THE MANUFACTURE AND MODIFICATION OF STEM CELLS, DIFFERENTIATED CELLS, CELL POPULATIONS AND THEIR BY-PRODUCTS FOR CLINICAL MEDICAL USE; BIOLOGICAL PREPARATIONS, NAMELY, STEM CELLS AND DIFFERENTIATED CELLS, AND BIOLOGICAL COMPOSITIONS COMPRISING STEM CELLS, DIFFERENTIATED CELLS AND THEIR BY-PRODUCTS ALL FOR MEDICAL DIAGNOSTIC USE; ALL THE AFORESAID GOODS BEING FOR USE ON OR IN RELATION TO HUMAN AND ANIMAL CELLS; PHARMACEUTICAL PREPARATIONS, NAMELY, STEM CELLS AND DIFFERENTIATED CELLS AND PREPARATIONS COMPRISING STEM CELLS AND DIFFERENTIATED CELLS, FOR USE IN THE TREATMENT OF CANCER, DEGENERATIVE DISEASES, CONGENITAL DISEASES, GENETIC DISORDERS, INFECTIOUS DISEASES, ORGAN FAILURE, PARKINSON'S DISEASE, DIABETES, HEART DISEASE, NEUROLOGICAL CONDITIONS, MULTIPLE SCLEROSIS, SPINAL CORD DAMAGE, AUTO IMMUNE DISEASES, AND HUMAN IMMUNODEFICIENCY VIRUS (HIV)

CHEMICALS FOR USE IN THE MANUFACTURE AND MODIFICATION OF STEM CELLS FOR USE IN THE PHARMACEUTICAL, AGRICULTURAL, SCIENTIFIC RESEARCH, HORTICULTURAL AND FORESTRY INDUSTRIES; BIOLOGICAL CHEMICALS FOR USE IN THE MANUFACTURE AND MODIFICATION OF STEM CELLS, DIFFERENTIATED CELLS, CELL POPULATIONS AND THEIR BY-PRODUCTS FOR USE IN THE PHARMACEUTICAL, AGRICULTURAL, SCIENTIFIC RESEARCH, HORTICULTURAL AND FORESTRY INDUSTRIES; BIOLOGICAL CHEMICALS OBTAINED FROM STEM CELLS, DIFFERENTIATED CELLS, CELL POPULATIONS AND THEIR BY-PRODUCTS FOR USE IN THE PHARMACEUTICAL, AGRICULTURAL, SCIENTIFIC RESEARCH, HORTICULTURAL AND FORESTRY INDUSTRIES

MEDICAL INSTRUMENTS USED IN THE PRODUCTION, MODIFICATION AND PREPARATION OF STEM CELLS, DIFFERENTIATED CELLS AND CELL POPULATIONS FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF DISEASES AND CONDITIONS IN HUMANS AND ANIMALS; MEDICAL INSTRUMENTS FOR USE IN STEM CELL PRODUCTION AND DIFFERENTIATION DEVICES AND FOR CONTAINING, STORING AND DELIVERING PREPARED STEM CELLS, DIFFERENTIATED CELLS AND CELL POPULATIONS FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF DISEASES AND CONDITIONS IN HUMANS AND ANIMALS; ALL THE AFORESAID GOODS BEING FOR USE ON OR IN RELATION TO HUMAN AND ANIMAL CELLS

MEDICAL RESEARCH SERVICES; TECHNICAL CONSULT ION AND RESEARCH IN THE FIELDS OF MODIFYING, PREPARING AND ADMINISTERING CELLS, CELL POPULATIONS, MODIFIED CELLS, MODIFIED CELL POPULATIONS AND THEIR BY-PRODUCTS; ALL THE AFORESAID SERVICES BEING FOR USE ON OR IN RELATION TO HUMAN AND ANIMAL CELLS

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Feb 19, 2016 CAEX
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 12, 2011 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 12, 2011 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 12, 2011 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 5, 2011 E815
REGISTERED-PRINCIPAL REGISTER
Jul 12, 2005 R.PR
PUBLISHED FOR OPPOSITION
Apr 19, 2005 PUBO
NOTICE OF PUBLICATION
Mar 30, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 24, 2005 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 4, 2004 CNSA
ASSIGNED TO LIE
Sep 22, 2004 ALIE
EXAMINERS AMENDMENT MAILED
Sep 21, 2004 CNEA
EXAMINER'S AMENDMENT ENTERED
Sep 20, 2004 XAEC
EXAMINERS AMENDMENT -WRITTEN
Sep 20, 2004 CNEA
FINAL REFUSAL MAILED
May 20, 2004 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2004 CRFA
PAPER RECEIVED
Feb 13, 2004 MAIL
NON-FINAL ACTION MAILED
Aug 18, 2003 CNRT
CASE FILE IN TICRS
Jun 7, 2003 CFIT
Sec. 1(B) CLAIM DELETED
May 9, 2003 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2003 CRFA
PAPER RECEIVED
May 9, 2003 MAIL
LETTER OF SUSPENSION MAILED
Feb 7, 2003 CNSL
UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Feb 4, 2003 UNPR
PAPER RECEIVED
Feb 4, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 30, 2002 CRFA
PAPER RECEIVED
Oct 30, 2002 MAIL
LETTER OF SUSPENSION MAILED
Jan 10, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2001 CRFA
NON-FINAL ACTION MAILED
Apr 25, 2001 CNRT
ASSIGNED TO EXAMINER
Apr 21, 2001 DOCK
ASSIGNED TO EXAMINER
Apr 10, 2001 DOCK